Filing Details

Accession Number:
0001209191-11-033964
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-10 09:56:22
Reporting Period:
2011-06-08
Filing Date:
2011-06-10
Accepted Time:
2011-06-10 08:56:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1046336 S Kenneth Boger C/O Vertex Pharmaceuticals Incorporated
130 Waverly St
Cambridge MA 02176
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-08 7,333 $18.75 120,332 No 4 M Direct
Common Stock Disposition 2011-06-08 7,333 $53.38 112,999 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2011-06-08 7,333 $0.00 7,333 $18.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
73,335 2011-09-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,021 Indirect 401(k)
Common Stock 174,167 Indirect Trustee of Trusts
Footnotes
  1. Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $53.38 (range $52.98 to $54.12).
  3. Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer).
  5. Fully vested.